EntrepreneurialCheck

Cambridge Cancer Genomics valuation

The estimated Cambridge Cancer Genomics valuation is $1.0M. This Cambridge Cancer Genomics valuation is an independent model output, not a verified appraisal, official mark, or financial advice. Founders: Evaline Tsai net worth, Harry Clifford net worth, and Nirmesh Patel net worth.

Evaline Tsai
CPO
$19K
Harry Clifford
CTO
$19K
Nirmesh Patel
Chief Scientific Officer
$19K

Search this company in the directory

FAQ: Cambridge Cancer Genomics valuation and founders net worth

What is Cambridge Cancer Genomics's valuation?

The estimated Cambridge Cancer Genomics valuation is $1.0M. This Cambridge Cancer Genomics valuation is an independent model output, not a verified appraisal, official mark, or financial advice.

How much did Cambridge Cancer Genomics raise?

How much Cambridge Cancer Genomics raised, when disclosed, informs the estimated Cambridge Cancer Genomics valuation and Cambridge Cancer Genomics founders net worth on this hub. Independent estimate only — not financial advice.

Who founded Cambridge Cancer Genomics?

Evaline Tsai, Harry Clifford, and Nirmesh Patel founded Cambridge Cancer Genomics. Estimated net worth for each founder is on the linked profile. Figures are independent model estimates, not verified net worth.